Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients

Journal of the Neurological Sciences

Volumn 185, Issue 1, 2001, Pages 19-26

  Bakshi, Rohit ^a,b,d   Dmochowski, Jacek ^c   Shaikh, Zubair A ^a   Jacobs, Lawrence ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b GATES VASCULAR INSTITUTE AT KALEIDA HEALTH   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d Neuroscience Center E 2   (United States)

Author keywords

Brain; Iron; MRI; Multiple sclerosis; T2 shortening

Indexed keywords

ARTICLE; BRAIN ATROPHY; DISEASE COURSE; GRAY MATTER; HUMAN; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; WHITE MATTER;

ADOLESCENT; ADULT; ATROPHY; BRAIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SENILE PLAQUES;

EID: 0035869389     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(01)00477-4     Document Type: Article

References (54)

1. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis
2. Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patients with and without multiple sclerosis
3. Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis
4. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
5. Microscopic disease in normal appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements
6. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group
7. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS)
8. Neuropathology in multiple sclerosis: new concepts
9. Axonal transection in the lesions of multiple sclerosis
10. Cortical lesions in multiple sclerosis
11. Cortical plaques visualised by fluid-attenuated inversion recovery imaging in relapsing multiple sclerosis
12. High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis
13. A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS
14. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS
15. MRI T2 shortening ('Black T2') in multiple sclerosis: frequency, location, and clinical correlation
16. Magnetic resonance imaging T2 shortening in multiple sclerosis brains (Black T2 Lesions): a new surrogate marker of disease (abstract)
17. New diagnostic criteria for multiple sclerosis: guidelines for research protocols
18. For the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey
19. Fluid-attenuated inversion-recovery MR imaging in acute and subacute cerebral intraventricular hemorrhage
20. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content
21. Biological significance of iron-related magnetic resonance imaging changes in the brain
22. Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease
23. A decrease in cerebral cortex intensity on T2-weighted images with ageing images of normal subjects
24. Reduced signal intensity on MR Images of thalamus and putamen in multiple sclerosis: increased iron content?
25. Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients
26. Quality of life and its relationship to brain lesions and atrophy on magnetic resonance images in 60 patients with multiple sclerosis
27. Brain MRI lesions and atrophy are related to depression in multiple sclerosis
28. Estimating dimension of the model
29. Multivariate adaptive regression splines
30. Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis
31. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
32. A longitudinal study of brain atrophy in relapsing multiple sclerosis
33. Progressive cerebral atrophy in multiple sclerosis: a serial MRI study
34. A Wallerian degeneration pattern in patients at risk for MS
35. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis
36. MRI hemispheric atrophy is associated with FDG-PET hypometabolism and MRI white matter lesions in multiple sclerosis (abstract)
37. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions
38. Signal intensity on MRI of basal ganglia in multiple sclerosis
39. Cortical and subcortical T2 shortening in multiple sclerosis
40. Magnetic resonance imaging in multiple sclerosis: decreased signal in thalamus and putamen
41. Brain magnetic resonance imaging in clinical neurology
42. Ferritin, transferrin, and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients
43. Iron deposits in multiple sclerosis and Alzheimer's disease brains
44. Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains
45. Iron deposits surrounding multiple sclerosis plaques
46. Iron and oxygen radicals in brain
47. MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images
48. T2 hypointensity in gray matter of MS patients: a quantitative study (abstract)
49. Bicaudate ratio as a marker of brain atrophy in multiple sclerosis: a quantitative MRI study (abstract)